Zhu Y, Lu Z, Wang Z, Liu J, Ning K
Front Immunol. 2025; 16:1480496.
PMID: 39958351
PMC: 11825815.
DOI: 10.3389/fimmu.2025.1480496.
Adejumo I
Genes Nutr. 2024; 19(1):21.
PMID: 39425027
PMC: 11490116.
DOI: 10.1186/s12263-024-00755-4.
Johnson B, Cheng L, Koenitzer J, Catlett I, Schafer P
Front Immunol. 2024; 15:1437512.
PMID: 39403378
PMC: 11472182.
DOI: 10.3389/fimmu.2024.1437512.
Rokade S, Damani A, Oft M, Emmerich J
Front Immunol. 2024; 15:1433989.
PMID: 39114660
PMC: 11303236.
DOI: 10.3389/fimmu.2024.1433989.
Nilsson M, Kozyrev S, Saellstrom S, Johansson S, Andersson G, Lindblad-Toh K
Sci Rep. 2024; 14(1):11624.
PMID: 38773194
PMC: 11109178.
DOI: 10.1038/s41598-024-62265-y.
The efficacy and safety of short-term and low-dose IL-2 combined with tocilizumab to treat rheumatoid arthritis.
Zhang S, Chen H, Wang J, Shao H, Cheng T, Pei R
Front Immunol. 2024; 15:1359041.
PMID: 38711497
PMC: 11070481.
DOI: 10.3389/fimmu.2024.1359041.
Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer.
Shouse A, LaPorte K, Malek T
Immunity. 2024; 57(3):414-428.
PMID: 38479359
PMC: 11126276.
DOI: 10.1016/j.immuni.2024.02.001.
Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes.
Lee K, Epstein B, Lake C, Snow A
Front Cell Death. 2023; 2.
PMID: 38074985
PMC: 10705843.
DOI: 10.3389/fceld.2023.1281137.
Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases.
Tomasovic L, Liu K, VanDyke D, Fabilane C, Spangler J
BioDrugs. 2023; 38(2):227-248.
PMID: 37999893
PMC: 10947368.
DOI: 10.1007/s40259-023-00635-0.
Low-dose interleukin-2 therapy in systemic lupus erythematosus.
La Cava A
Rheumatol Immunol Res. 2023; 4(3):150-156.
PMID: 37781677
PMC: 10538619.
DOI: 10.2478/rir-2023-0021.
"IL-2 immunotherapy for targeting regulatory T cells in autoimmunity".
Lykhopiy V, Malviya V, Humblet-Baron S, Schlenner S
Genes Immun. 2023; 24(5):248-262.
PMID: 37741949
PMC: 10575774.
DOI: 10.1038/s41435-023-00221-y.
Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells.
Inaba A, Tuong Z, Zhao T, Stewart A, Mathews R, Truman L
Nat Commun. 2023; 14(1):2071.
PMID: 37045832
PMC: 10097719.
DOI: 10.1038/s41467-023-37424-w.
STAT5b: A master regulator of key biological pathways.
Smith M, Forbes Satter L, Vargas-Hernandez A
Front Immunol. 2023; 13:1025373.
PMID: 36755813
PMC: 9899847.
DOI: 10.3389/fimmu.2022.1025373.
Soluble CD25 imposes a low-zone IL-2 signaling environment that favors competitive outgrowth of antigen-experienced CD25 regulatory and memory T cells.
Nickle R, DeOca K, Garcia B, Mannie M
Cell Immunol. 2023; 384:104664.
PMID: 36642016
PMC: 10257407.
DOI: 10.1016/j.cellimm.2023.104664.
IL-2-based approaches to Treg enhancement.
Harris F, Berdugo Y, Tree T
Clin Exp Immunol. 2022; 211(2):149-163.
PMID: 36399073
PMC: 10019135.
DOI: 10.1093/cei/uxac105.
IL-2 and IL-15 drive intrathymic development of distinct periphery-seeding CD4Foxp3 regulatory T lymphocytes.
Apert C, Galindo-Albarran A, Castan S, Detraves C, Michaud H, McJannett N
Front Immunol. 2022; 13:965303.
PMID: 36159793
PMC: 9495261.
DOI: 10.3389/fimmu.2022.965303.
Emerging principles of cytokine pharmacology and therapeutics.
Saxton R, Glassman C, Garcia K
Nat Rev Drug Discov. 2022; 22(1):21-37.
PMID: 36131080
PMC: 10292932.
DOI: 10.1038/s41573-022-00557-6.
Dendritic cell-derived IL-27 p28 regulates T cell program in pathogenicity and alleviates acute graft-versus-host disease.
Gong H, Ma S, Chen J, Yang B, Liu S, Liu X
Signal Transduct Target Ther. 2022; 7(1):319.
PMID: 36109504
PMC: 9477797.
DOI: 10.1038/s41392-022-01147-z.
Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans.
Harley I, Allison K, Scofield R
Front Immunol. 2022; 13:953439.
PMID: 36090990
PMC: 9450536.
DOI: 10.3389/fimmu.2022.953439.
Immunoregulation via Cell Density and Quorum Sensing-like Mechanisms: An Underexplored Emerging Field with Potential Translational Implications.
Naoun A, Raphael I, Forsthuber T
Cells. 2022; 11(15).
PMID: 35954285
PMC: 9368058.
DOI: 10.3390/cells11152442.